Dermata Therapeutics- Warrants (13/08/2026) Goodwill

Dermata Therapeutics- Warrants (13/08/2026) (DRMAW) currently reports a goodwill of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Dermata Therapeutics- Warrants (13/08/2026)'s goodwill history and peer comparisons.

Dermata Therapeutics- Warrants (13/08/2026)'s goodwill changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Dermata Therapeutics- Warrants (13/08/2026) reported $0 in goodwill as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Dermata Therapeutics- Warrants (13/08/2026), and consider following DRMAW for alerts when major investors trade the stock.

Dermata Therapeutics- Warrants (13/08/2026) is classified in the Healthcare sector. On goodwill, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DRMAW with unrelated industries.